BI 1034020
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BI 1034020, covering 2015-07-30 to 2015-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy Volunteers [Phase 1]